EW Stock Analysis: Buy, Sell, or Hold?
EW - Edwards Lifesciences Corp
$81.36
-0.13 (-0.16%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 10, 2026
9d
Get Alerted When EW Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: EW shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
📊 HOLD: EW shows mixed signals. Fine to hold existing positions. Not urgent to buy or sell.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$108.14
Based on 8.3% avg growth
INTRINSIC VALUE TODAY
$67.15
Trading above fair value
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: EW is currently trading at $81.36, which is considered oversold relative to its 30-day fair value range of $83.01 to $86.01. The stock's valuation (Forward PE: 28.0) is in line with its historical norms (29.4). Remarkably, the market is currently pricing in an annual earnings decline of 1.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, EW is in a strong uptrend. The price is currently testing key support at $80.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EW has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $97.02 (+19.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, EW is in a strong uptrend. The price is currently testing key support at $80.44. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: EW has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $97.02 (+19.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$83.01 -
$86.01
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
54.8%
Protect Your Profits
Holding EW? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($97.02)
Fair Price Analysis
30-Day Fair Range
$83.01 -
$86.01
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$80.44
Resistance Level
$86.20
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
28.01
Wall Street Target
$97.02
(+19.1%)
Revenue Growth (YoY)
14.7%
Earnings Growth (YoY)
-90.3%
Profit Margin
23.2%
Valuation Discount vs History
-1.5% cheaper
PE vs Historical
28.0 vs 29.4
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-1.5%
(market-implied from PE analysis)
1-Year Target
$80.27
(-2%)
2-Year Target
$79.06
(-3%)
3-Year Target
$77.88
(-4%)
3-Yr Target (if PE normalizes)
(PE: 28→29)
$81.74
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 28.0, Growth: 12.6%)
$116.29
(+43%)
Base:
(SPY PE: 22.3, Growth: 12.6%)
$92.58
(+14%)
Bear:
(PE: 19.0, Growth: 12.6%)
$78.69
(-3%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (36x PE), but valuation improves significantly next year (28x PE) as earnings recover.
Trailing PE: 35.90 | Current EPS (TTM): $2.28
Bull Case
$114.90
(+41%)
Analyst growth 27.6%, PE expands to 39.5
Base Case
$104.45
(+28%)
Market implied 27.6%, PE stable at 35.9
Bear Case
$55.66
(-32%)
Severe decline -20.0%, PE contracts to 30.5
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 28.0 to 29.4
Stabilization Target:
$85.53
(+5.0%)
PE Expansion Potential:
+5.0%
Last updated: January 31, 2026 1:04 AM ET
Data refreshes hourly during market hours. Next update: 2:04 AM
Data refreshes hourly during market hours. Next update: 2:04 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is EW showing a specific setup today?
Insider Activity (6 Months)
0
Buys
1
Sells
Net
INSIDERS SELLING
Recent Transactions
Larry L Wood
SELL
8950 shares
2025-08-18
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$124 | 59 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$427 | 68 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
26 analysts |
$85 | 65 BUY |
|
ABT
Abbott Laboratories |
BUY
28 analysts |
$136 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$110 | 63 BUY |
Advanced EW Option Strategies
Professional options setups generated by AI based on today's EW price and gamma walls.
